Short Interest in Terumo Co. (OTCMKTS:TRUMY) Decreases By 47.4%

Terumo Co. (OTCMKTS:TRUMY) was the target of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 17,200 shares, a decrease of 47.4% from the December 31st total of 32,700 shares. Based on an average daily volume of 133,300 shares, the days-to-cover ratio is presently 0.1 days.

Terumo Stock Performance

Shares of TRUMY stock traded up $0.03 during mid-day trading on Friday, hitting $19.54. The stock had a trading volume of 932,567 shares, compared to its average volume of 154,783. Terumo has a fifty-two week low of $14.06 and a fifty-two week high of $21.22. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.94 and a quick ratio of 1.70. The company’s 50-day simple moving average is $19.61 and its 200-day simple moving average is $19.00. The firm has a market cap of $28.93 billion, a PE ratio of 41.07 and a beta of 0.65.

Terumo (OTCMKTS:TRUMY) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.13 earnings per share for the quarter. The business had revenue of $1.68 billion during the quarter.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.